Gossamer Bio, Inc. (GOSS)
NASDAQ: GOSS · Real-Time Price · USD
3.600
-0.020 (-0.55%)
At close: Dec 12, 2025, 4:00 PM EST
3.720
+0.120 (3.33%)
After-hours: Dec 12, 2025, 6:53 PM EST
Gossamer Bio Market Cap
Gossamer Bio has a market cap or net worth of $833.24 million as of December 12, 2025. Its market cap has increased by 425.30% in one year.
Market Cap
833.24M
Enterprise Value
855.89M
1-Year Change
425.30%
Ranking
Category
Stock Price
$3.60
Market Cap Chart
Since February 8, 2019, Gossamer Bio's market cap has decreased from $995.26M to $833.24M, a decrease of -16.28%. That is a compound annual growth rate of -2.56%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 12, 2025 | 833.24M | 306.49% |
| Dec 31, 2024 | 204.99M | -0.34% |
| Dec 29, 2023 | 205.69M | 0.56% |
| Dec 30, 2022 | 204.54M | -76.06% |
| Dec 31, 2021 | 854.34M | 21.87% |
| Dec 31, 2020 | 701.04M | -26.45% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Feb 8, 2019 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 920.02B |
| Johnson & Johnson | 509.76B |
| AbbVie | 394.69B |
| UnitedHealth Group | 309.65B |
| AstraZeneca | 278.45B |
| Novartis AG | 254.39B |
| Merck & Co. | 248.95B |
| Novo Nordisk | 224.22B |